Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 475 of 2051 entries
View as:

An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

Phase: N/A Priority: Normal
NCT ID: NCT00132730 Org: User:
Start: 06/01/04 End: 08/17/05 Due: 08/17/06

Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00440531 Org: User:
Start: 11/30/06 End: 11/30/07 Due: 11/30/08

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)

Phase: N/A Priority: Normal
NCT ID: NCT02251990 Org: User:
Start: 01/28/15 End: 04/10/17 Due: 04/10/18

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00535730 Org: User:
Start: 06/30/07 End: 02/29/08 Due: 02/28/09

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00109538 Org: User:
Start: 05/31/05 End: 08/31/08 Due: 08/31/09

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00127101 Org: User:
Start: 09/30/05 End: 10/31/08 Due: 10/31/09

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Phase: N/A Priority: Normal
NCT ID: NCT03643952 Org: User:
Start: 12/06/18 End: 04/07/20 Due: 04/07/21

Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)

Phase: N/A Priority: Normal
NCT ID: NCT02787005 Org: User:
Start: 07/01/16 End: 02/28/22 Due: 02/28/23

Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)

Phase: N/A Priority: Normal
NCT ID: NCT00620113 Org: User:
Start: 12/03/07 End: 05/29/09 Due: 05/29/10

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT00518687 Org: User:
Start: 12/31/07 End: 08/31/11 Due: 08/31/12

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Phase: N/A Priority: Normal
NCT ID: NCT00599755 Org: User:
Start: 01/01/09 End: 04/13/11 Due: 04/13/12

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00140933 Org: User:
Start: 04/30/03 End: - Due: -

Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)

Phase: N/A Priority: Normal
NCT ID: NCT02702414 Org: User:
Start: 05/31/16 End: 09/29/23 Due: 09/29/24

MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)

Phase: N/A Priority: Normal
NCT ID: NCT00103857 Org: User:
Start: 03/17/05 End: 02/21/08 Due: 02/21/09

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00564447 Org: User:
Start: 12/31/07 End: - Due: -

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

Phase: N/A Priority: Normal
NCT ID: NCT06353386 Org: User:
Start: 05/20/24 End: 03/31/28 Due: 03/31/29

Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)

Phase: N/A Priority: Normal
NCT ID: NCT04895722 Org: User:
Start: 06/25/21 End: 04/30/26 Due: 04/30/27

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Phase: N/A Priority: Normal
NCT ID: NCT00091572 Org: User:
Start: 10/20/04 End: 12/31/07 Due: 12/31/08

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00533598 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A)

Phase: N/A Priority: Normal
NCT ID: NCT06428409 Org: User:
Start: 06/20/24 End: 10/16/29 Due: 10/16/30

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

Phase: N/A Priority: Normal
NCT ID: NCT00087516 Org: User:
Start: 06/30/04 End: 02/28/07 Due: 02/28/08

An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)

Phase: N/A Priority: Normal
NCT ID: NCT00130806 Org: User:
Start: 09/30/05 End: 11/30/05 Due: 11/30/06

Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)

Phase: N/A Priority: Normal
NCT ID: NCT01021852 Org: User:
Start: 11/30/09 End: 02/01/11 Due: 02/01/12

A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)

Phase: N/A Priority: Normal
NCT ID: NCT01313520 Org: User:
Start: 03/01/11 End: 03/01/12 Due: 03/01/13

MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00449956 Org: User:
Start: 03/12/07 End: 02/16/08 Due: 02/16/09